HealthDay on MSN5d
New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the field of ...
Daily2d
Elective Peri-Operative Management of Patients on GLP-1, GIP Agonists & SGLT-2 Inhibitors: Multidisciplinary Consensus Released
UK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the ...
Medscape6d
Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Medscape8h
GLP-1 Reduces Recurrent Ischemic Stroke in Type 2 Diabetes
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Healio1d
Addiction, depression, cognition: How GLP-1s may benefit the brain
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
Endocrinology Advisor3d
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.
Senators call on FDA to act against misleading weight-loss drug commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...
Healio1d
SGLT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
HealthDay on MSN1d
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in ...
clinicaladvisor.com6d
Treating Alcohol Use Disorder: GLP-1s Emerge as a Promising New Therapy
Glucagon-like peptide-1 (GLP-1) is a hormone that regulates the reward response in this complex pathway. GLP-1 hormones interact with receptors in multiple brain regions to induce various ...